With the mission of “promoting professional promotion and serving public health”, the company is committed to professional academic promotion; meets the unmet therapeutic needs of patients, and focuses on serving patients' health.
With the mission of "being a health promoter and serving the public", the company is committed to professional academic promotion, patient needs and health service.
With the mission of “promoting professional promotion and serving public health”, the company is committed to professional academic promotion; meets the unmet therapeutic needs of patients, and focuses on serving patients' health.
Chongqing Jingdong Junzhuo Pharmaceutical Co., Ltd. attaches great importance to the international market. We pay attention to the international development and effects of new drugs, build a channel for product communication.
With the mission of “promoting professional promotion and serving public health”, the company is committed to professional academic promotion; meets the unmet therapeutic needs of patients, and focuses on serving patients' health.
Follow no set form, be enthusiastic and active, diligent and eager to learn, possessing both political integrity and ability. Talents are symbols of company value, shareholders are creators of value and one of the key elements of company competitiveness and the first factor to achieve the scientific development of the company.
| 【Ingredients】 |
|
|---|---|
| 【Character】 |
This product is a yellow to brownish yellow clear oily liquid. |
| 【Indication】 |
1. Docetaxel is suitable for the treatment of advanced or metastatic breast cancer with failed prior chemotherapy. Unless it is a clinical contraindication, pre-treatment should include an anthracycline anticancer drug. 2. Docetaxel is suitable for the treatment of advanced or metastatic non-small cell lung cancer with cisplatin-based chemotherapy failure. |
| 【Specifications】 |
20mg |
| 【usage and dosage】 |
Docetaxel can only be used for intravenous drip. All patients must receive oral glucocorticoids, such as dexamethasone, before docetaxel infusion, 16 mg daily for at least 3 days to prevent allergic reactions and fluid retention before receiving docetaxel treatment. . The recommended dose for docetaxel is 70-75 mg/m2, which is administered intravenously for one hour every three weeks. Please refer to the manual for details. |
- Scan code pays attention to us -
National customer service：400 969 7233
Company address：F13, Building A, Shenzhou Zhihui Tiandi, 26 Honghu West Road, Yubei District, Chongqing Municipality
簡體中文
English
